BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38881110)

  • 1. A Study of Cerebral Venous Sinus Thrombosis with Special Reference to Newer Risk Predictors.
    Khambholja J; Panchal SS; Gami JI
    J Assoc Physicians India; 2024 May; 72(5):45-56. PubMed ID: 38881110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Thrombo-inflammatory Biomarkers in the Prognosis of Cerebral Venous Sinus Thrombosis.
    Karahan SZ; Gazioglu S; Dilaver I; Boz C
    Curr Neurovasc Res; 2021; 18(2):237-243. PubMed ID: 34109909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of platelet to lymphocyte and neutrophil to lymphocyte ratios in predicting the presence of cerebral venous sinus thrombosis and in-hospital major adverse cerebral events.
    Akboga YE; Bektas H; Anlar O
    J Neurol Sci; 2017 Sep; 380():226-229. PubMed ID: 28870575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of systemic immune-inflammation index in acute/subacute patients with cerebral venous sinus thrombosis.
    Li S; Liu K; Gao Y; Zhao L; Zhang R; Fang H; Tao Y; Liu H; Zhao J; Xia Z; Xu Y; Song B
    Stroke Vasc Neurol; 2020 Dec; 5(4):368-373. PubMed ID: 32586971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebral venous thrombosis requiring invasive treatment for elevated intracranial pressure in women with combined hormonal contraceptive intake: risk factors, anatomical distribution, and clinical presentation.
    Roethlisberger M; Gut L; Zumofen DW; Fisch U; Boss O; Maldaner N; Croci DM; Taub E; Corti N; Burkhardt JK; Guzman R; Bozinov O; Mariani L
    Neurosurg Focus; 2018 Jul; 45(1):E12. PubMed ID: 29961388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glasgow Coma Scale ≤ 12 at Admission is a Predictor of Poor Functional Outcome (mRS 2-6) at One Year in Patients with Cerebral Venous Thrombosis.
    Gupta S; Soni R; Dhull P; Somasekharan M; Sreen A
    J Stroke Cerebrovasc Dis; 2021 Jul; 30(7):105811. PubMed ID: 33915391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory biomarkers are correlated with thrombus burden in cerebral venous sinus thrombosis.
    Yaman Kula A; Kurtoğlu AV; Güzel V; Balsak S; Yabacı Tak A; Asil T
    Arq Neuropsiquiatr; 2024 May; 82(5):1-8. PubMed ID: 38811022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of admission clinical predictors and functional outcome in patients with Cerebral Venous and Dural Sinus Thrombosis.
    Ortega-Gutierrez S; Holcombe A; Aksan N; Dai B; Shaban A; Lazarre L; Zheng-Lin B; Sager L; Dandapat S; Siddiqui FM; Mohr NM
    Clin Neurol Neurosurg; 2020 Jan; 188():105563. PubMed ID: 31783304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of hospital outcome in patients with cerebral venous thrombosis.
    Korathanakhun P; Sathirapanya P; Geater SL; Petpichetchian W
    J Stroke Cerebrovasc Dis; 2014; 23(10):2725-2729. PubMed ID: 25307433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebral Venous Sinus Thrombosis Score and its Correlation with Clinical and MRI Findings.
    Kalita J; Singh VK; Jain N; Misra UK; Kumar S
    J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104324. PubMed ID: 31422004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Value of Neutrophil to Lymphocyte and Platelet to Lymphocyte Ratio After Aneurysmal Subarachnoid Hemorrhage.
    Tao C; Wang J; Hu X; Ma J; Li H; You C
    Neurocrit Care; 2017 Jun; 26(3):393-401. PubMed ID: 28028791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The clinical characteristics of neutrophil extracellular trap in patients with severe cerebral venous sinus thrombosis and its prognostic value in acute and subacute patients].
    Wang W; Jia Q; Wang SB; Li XD; Fan YM
    Zhonghua Wai Ke Za Zhi; 2024 May; 62(5):443-451. PubMed ID: 38548615
    [No Abstract]   [Full Text] [Related]  

  • 13. Association of neutrophil to lymphocyte ratio and D-dimer with functional outcome in patients with cerebral venous sinus thrombosis.
    Sun R; Huang F; Wu W; Yin G; Ding Q; Gu Z; Fan C; Song C; Liang M; Liu X; Bi X
    BMC Neurol; 2023 Jan; 23(1):30. PubMed ID: 36658518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting poor response to anti-coagulation therapy in cerebral venous thrombosis using a simple clinical-radiological score.
    Montalvan V; Neves G; Bueso T; Ota R; Bushnaq S; Windisch T; Bushnaq S
    J Clin Neurosci; 2022 Nov; 105():26-30. PubMed ID: 36058024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and radiological characteristics and predictors of outcome of cerebral venous sinus thrombosis, a hospital-based study.
    Shakibajahromi B; Haghighi AB; Salehi A; Vardanjani HM; Ghaedian M; Safari A; Mowla A
    Acta Neurol Belg; 2020 Aug; 120(4):845-852. PubMed ID: 30178180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical course of cerebral sinus venous thrombosis. Data from a monocentric cohort study over 15 years].
    Geisbüsch C; Lichy C; Richter D; Herweh C; Hacke W; Nagel S
    Nervenarzt; 2014 Feb; 85(2):211-20. PubMed ID: 24469382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Association between Inflammation and Cerebral Venous Thrombosis: A Retrospective Study.
    Zhang X; Ding R; Li H; Liu Y; Ou W; Hu J; Tian Y; Wang Q
    J Stroke Cerebrovasc Dis; 2021 Nov; 30(11):106084. PubMed ID: 34507256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic immune inflammation index and peripheral blood carbon dioxide concentration at admission predict poor prognosis in patients with severe traumatic brain injury.
    Chen L; Xia S; Zuo Y; Lin Y; Qiu X; Chen Q; Feng T; Xia X; Shao Q; Wang S
    Front Immunol; 2022; 13():1034916. PubMed ID: 36700228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of systemic immune-inflammation index in acute deep vein thrombosis: A propensity-matched.
    Tort M; Sevil FC; Sevil H; Becit N
    J Vasc Surg Venous Lymphat Disord; 2023 Sep; 11(5):972-977.e1. PubMed ID: 37003462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.